AU Patent

AU2016379292B2 — α, β unsaturated amide compound

Assigned to Kyowa Kirin Co Ltd · Expires 2021-03-25 · 5y expired

What this patent protects

The invention provides an α,β unsaturated amide compound having anticancer activity shown by formula (I) or a pharmaceutically acceptable salt or the like thereof: [in the formula, A represents an optionally substituted heterocyclic diyl, R

USPTO Abstract

The invention provides an α,β unsaturated amide compound having anticancer activity shown by formula (I) or a pharmaceutically acceptable salt or the like thereof: [in the formula, A represents an optionally substituted heterocyclic diyl, R

Drugs covered by this patent

Patent Metadata

Patent number
AU2016379292B2
Jurisdiction
AU
Classification
—
Expires
2021-03-25
Drug substance claim
No
Drug product claim
No
Assignee
Kyowa Kirin Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.